HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies Methodological
Partitioned survival and state transition models for healthcare decision making in oncology: where are we now? Methodological
Exploring heterogeneity in histology-independent technologies and the implications for cost-effectiveness Methodological
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies Methodological
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma Methodological
